Philippine officials pull Dengvaxia’s marketing license, but Sanofi asks them to reconsider – FiercePharma

Sanofi set off an uproar in the Philippines with its 2017 disclosure that dengue shot Dengvaxia can cause more serious infections in some cases. Now, after investigations and more, the country’s FDA has permanently revoked the vaccine’s marketing license.  Citing “brazen defiance” from the drugmaker and saying Sanofi failed to meet its postmarketing requirements, the Philippines FDA pulled Dengvaxia’s regulatory approval, Reuters reports.  The decision may not come as a surprise to market watchers, considering the tough stance officials in the Philippines took after Sanofi’s safety disclosure back at the end of 2017. The company said new trial analyses showed its vaccine can cause more serious ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 2

Ähnlich Nachrichten